Cenobamate significantly improves seizure control in intellectually disabled patients with drug-resistant epilepsy and allows drug load reduction

IntroductionEpilepsy patients with intellectual disability often suffer from drug-resistant epilepsy (DRE), which severely affects patients’ quality of life. Cenobamate (CNB) is a recently approved novel and effective ASM that can achieve high rates of seizure freedom in previously drug-resistant pa...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Anna-Lena Friedo, Benedikt Greshake, Konstantin L. Makridis, Hans-Beatus Straub
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2023-07-01
סדרה:	Frontiers in Neurology
נושאים:	cenobamate drug resistant epilepsy seizure freedom intellectual disability drug load anti-seizure medication
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1209487/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!